SVB Leerink Initiates Coverage On Oak Street Health with Market Perform Rating, Announces Price Target of $51
SVB Leerink analyst Whit Mayo initiates coverage on Oak Street Health (NYSE:OSH) with a Market Perform rating and announces Price Target of $51.
Looking Into Oak Street Health’s Return On Capital Employed
Oak Street Health (NYSE:OSH) brought in sales totaling $353.10 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 55.64%, resulting in a loss of $99.30 million.
Expert Ratings For Oak Street Health
Within the last quarter, Oak Street Health (NYSE:OSH) has observed the following analyst ratings:
Cowen & Co. Initiates Coverage On Oak Street Health with Outperform Rating, Announces Price Target of $61
Cowen & Co. analyst Gary Taylor initiates coverage on Oak Street Health (NYSE:OSH) with a Outperform rating and announces Price Target of $61.
Analyst Ratings For Oak Street Health
Within the last quarter, Oak Street Health (NYSE:OSH) has observed the following analyst ratings:
Goldman Sachs Initiates Coverage On Oak Street Health with Buy Rating, Announces Price Target of $76
Goldman Sachs analyst Jamie Perse initiates coverage on Oak Street Health (NYSE:OSH) with a Buy rating and announces Price Target of $76.
